3,4-dihydroxyphenylglycol has been researched along with halothane in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hunter, LW; Lunn, JJ; Rorie, DK | 1 |
| Kamath, GS; Rorie, DK; Tyce, GM | 1 |
| Carmichael, FJ; Crawford, MW; Gow, R; Shams, M; Thomas, ML | 1 |
3 other study(ies) available for 3,4-dihydroxyphenylglycol and halothane
| Article | Year |
|---|---|
Halothane decreases the release of neuropeptide Y and 3,4-dihydroxyphenylglycol from superfused segments of dog pulmonary artery.
Topics: Animals; Depression, Chemical; Dogs; Electric Stimulation; Female; Halothane; In Vitro Techniques; Male; Methoxyhydroxyphenylglycol; Neuropeptide Y; Norepinephrine; Pulmonary Artery; Sympathetic Nervous System | 1990 |
Altered release and metabolism of norepinephrine in superfused canine saphenous veins in the presence of halothane and hypoxia.
Topics: Animals; Dogs; Electric Stimulation; Female; Halothane; Hypoxia; Male; Methoxyhydroxyphenylglycol; Muscle Contraction; Muscle, Smooth, Vascular; Nerve Endings; Norepinephrine; Saphenous Vein; Sympathetic Nervous System; Tissue Distribution | 1993 |
The effect of magnesium deficiency on volatile anaesthetic requirement in the rat: the role of central noradrenergic neuronal activity.
Topics: Anesthetics, Inhalation; Animals; Brain; Diet; Halothane; Magnesium Deficiency; Male; Methoxyhydroxyphenylglycol; Methyl Ethers; Neurons; Norepinephrine; Rats; Rats, Sprague-Dawley; Sevoflurane; Time Factors | 2001 |